Stocks · Korea 302440 KOSPI

SK Bioscience

38,000원 +2.01% Market cap 3.0조 2026-10-07 close
Data as of 2026-10-07 · Linked from 11 pages
An overview for this page is not available in English yet. The figures below are updated daily.

Key figures 2026-10-07 basis

PER—
PBR1.67x
EPS0 KRW
BPS22,806 KRW
ROE-4.36%
DPS0 KRW

Returns and 52-week range

1W+6.00%
1M+0.66%
3M+0.80%
6M-12.94%
1Y-23.15%
YTD-20.83%
52W high61,300원
52W low31,800원
From 52W high-38.01%

Financial results (consolidated)

PeriodRevenueOperating incomeNet incomeOP margin
20224,567억1,150억1,225억25.2%
20233,695억-120억223억-3.2%
20242,675억-1,384억-501억-51.7%
20256,514억-1,235억-562억-19.0%
Quarterly
2024 4Q1,568억-508억-27억-32.4%
2025 1Q1,546억-151억-41억-9.8%
2025 2Q1,619억-374억-168억-23.1%
2025 3Q1,508억-194억211억-12.8%
2025 4Q1,842억-516억-564억-28.0%
2026 1Q1,686억-445억-362억-26.4%

Company

CEO안재용
Founded2018-07-01
Fiscal year end12
Address: 인천광역시 연수구 연구단지로 38 -

Peers in the same sector

CompanyMarket capP/EP/B1M
펩트론3.0조—21.37-32.20%
에이비엘바이오2.9조—18.20-24.41%
파마리서치3.2조19.415.18-19.03%
한올바이오파마2.4조—14.38-15.03%
유한양행5.5조28.862.43-7.86%
케어젠2.4조108.2710.23+1.03%

Recent filings

Source: DART (Financial Supervisory Service electronic disclosure)

Sources and notes

This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.